By modifying polyniobate on a metal-organic framework, scientists have managed to purify Cytochrome C for proteomic analysis using LC–MS/MS.
Researchers from Shenyang Medical College in Shenyang, PR China have developed a highly efficient and selective pretreatment method for Cytochrome C (Cyt-C) in real samples. The study, published in the Journal of Chromatography A, describes how polyniobate was modified on a metal-organic framework to create an aqueous-stable composite that can successfully purify complex protein samples (1). The resulting material, Nb6O19/MIL-125(Ti), was found to promote the selective adsorption of Cyt-C due to the synergistic effect of electrostatic and hydrogen-bond interactions.
Cytochrome P450 (CYP2D6) liver enzyme bound to quinine | Image Credit: © molekuul.be - stock.adobe.com
The study showed that at pH = 10.0, the adsorption efficiency of 300 μL of 100 μg·mL−1 Cyt-C onto 1.0 mg Nb6O19/MIL-125(Ti) can reach 99.5%. The adsorption behavior of Cyt-C fits well with the Langmuir adsorption model, corresponding to a maximum theoretical adsorption capacity of 168.35 mg/g. Using 3 mol/L NaCl as the eluent, a high elution efficiency of 92.19% is obtained.
In other words, Nb6O19/MIL-125(Ti) is a composite material that can selectively adsorb cytochrome C (Cyt-C) due to synergistic electrostatic and hydrogen-bond interactions. This composite material is prepared by modifying polyniobate (K7H[Nb6O19]·13H2O, Nb6O19) on a metal-organic framework MIL-125(Ti). At pH 10.0, Nb6O19/MIL-125(Ti) can efficiently adsorb Cyt-C, with an adsorption efficiency of 99.5% achieved using 1.0 mg of Nb6O19/MIL-125(Ti) for 300 μL of 100 μg/mL Cyt-C. Using 3 mol/L NaCl as the eluent, a high elution efficiency of 92.19% is obtained, making it suitable for the analysis of Cyt-C using LC–MS/MS.
The researchers demonstrated the practical application of Nb6O19/MIL-125(Ti) in scrofa heart proteomics. The sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis confirmed that Nb6O19/MIL-125(Ti) efficiently adsorbed Cyt-C from the scrofa heart extraction. LC–MS/MS spectrometry results show that the purification of Cyt-C reduces the abundance from the 12th to the 154th place after Nb6O19/MIL-125(Ti) treatment. Moreover, low abundant proteins, such as Superoxide dismutase 1, IF rod domain-containing protein, and Ubiquitin-60S ribosomal protein L40, were considerably enriched.
The IF rod domain-containing protein is a type of intermediate filament protein that is involved in maintaining the structural integrity of cells. It is widely distributed in many tissues and is particularly abundant in muscle cells. Ubiquitin-60S ribosomal protein L40 is a ribosomal protein that is involved in the regulation of protein synthesis. It has been shown to play a role in the degradation of misfolded or damaged proteins in cells.
Cyt-C is essential for electron transfer in cellular respiration and its abnormal release from mitochondria to the cytoplasm can cause various diseases. The content of Cyt-C in bio-samples is typically lower than the detection limit of commonly used methods, and complex matrix interference further complicates its analysis. Therefore, the study's success in exploring a new method and material for Cyt-C isolation is of great importance for proteomics. The researchers note that the material could have potential applications beyond scrofa heart proteomics, making it a promising development in the field.
(1) Wu, X.; Mao, Q; Hao, Y; Yang, J.; Zhang, X.; Chi, Z.; Liu, G.; Wang, M; Chen, Q.; Chen, X. Isolation of Cytochrome C for Proteomics with Lindqvist-type Polyiodate Modified Metal Organic Framework. J. Chromatogr. A 2023, 1693, 463869. DOI: https://doi.org/10.1016/j.chroma.2023.463869
FDA Grants Breakthrough Status to AI-Enhanced GC-MS Device for Bladder Cancer Detection
July 1st 2025A new cancer detection test to analyze volatile organic compounds through urine analysis, was granted the Breakthrough Device Designation status by the U.S. FDA. The system, which is built on gas chromatography–mass spectrometry (GC–MS) and proprietary AI, generates real-time cancer risk scores.